AstraZeneca bets on gene editing for broad range of new drugs
January 29, 2015 at 02:08 AM EST
LONDON, Jan 29 (Reuters) - AstraZeneca said on Thursday it had struck four research collaborations in the hot area of genome editing as it bets on a new technology to deliver better and more precise drugs for a range of diseases.